SynthesisCancer immunology, immunotherapy : CII2021

Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis.

E Suazo-Zepeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.